Atlas Trials

A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

Clinical trial NCT00298025 · COMPLETED

Trial details

NCT number
NCT00298025
Sponsor
EMD Serono
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Infertile Women Undergoing Assisted Reproductive Technology (ART)
Start date
2003-09-01
Primary completion
2004-05-01
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.